Childhood eczema: what actually calms the itch

The everyday treatments for childhood eczema that have real trial evidence behind them are unglamorous: apply moisturiser regularly to reduce flares, and use a topical steroid for the flares that break through [s1]. The effects are genuine but modest, no single moisturiser brand has been shown to beat another, and the most-hyped add-on — the "bleach bath" — works no better than a plain water bath in pooled trials [s1][s3].

What atopic eczema is

Atopic dermatitis, also called atopic eczema, is the most common inflammatory skin disease in the world, marked by dry skin, intense itch and a relapsing rash [s2]. It usually begins in infancy and affects up to 20% of children, with about 80% of affected children developing it before the age of 6 [s2]. It tends to be worst between the ages of two and four and often improves or clears after that, though it can persist: among young adults up to age 26 the prevalence is still 5 to 15% [s2]. The clinical picture is one of remission and relapse — acute flares of red, weeping, itchy skin on a background of chronic dryness — and it clusters with hay fever, asthma and food allergies in people with an "atopic tendency" [s2]. Roughly 230 million people worldwide are affected, and lifetime prevalence exceeds 15%, especially in wealthier countries [s2].

The base layer: moisturisers

Moisturisation is the foundation of treatment, and the largest evidence synthesis supports it — with honest caveats about size of effect. A Cochrane review pooled 77 randomised trials of 6,603 people with eczema (mean age 18.6 years, mean trial duration 6.7 weeks), so its findings span children and adults rather than children alone [s1]. Across the moisturiser-versus-control comparisons, moisturisers lowered investigator-assessed disease severity (standardised mean difference −1.04, 95% confidence interval −1.57 to −0.51) and roughly cut the flare rate by two-thirds (risk ratio 0.33, 95% CI 0.17 to 0.62) [s1].

The head-to-head against using no moisturiser at all is the most concrete. In those trials, moisturiser use meant fewer flares (risk ratio 0.40, 95% CI 0.23 to 0.70), a longer time to the next flare (a median of 180 days versus 30 days), and less topical steroid needed to control the disease (a mean difference of 9.30 grams less, 95% CI 15.3 to 3.27 grams less) [s1]. Combining a moisturiser with an active topical treatment beat the active treatment alone (standardised mean difference −0.87, 95% CI −1.17 to −0.57) [s1]. The review's other blunt conclusion matters for parents facing a wall of competing tubs: it found no reliable evidence that one moisturiser is better than another [s1].

The flare treatment: topical steroids

Moisturisers reduce flares but do not abolish them, and the standard approach layers a topical corticosteroid on top for active, inflamed skin. The clearest signal in the trial data is indirect but consistent — regular moisturising reduces the quantity of topical steroid a person needs to reach the same control, which is why emollients are described as steroid-sparing rather than steroid-replacing [s1]. The everyday worry that these creams are dangerous is out of proportion to how they are actually used in short courses matched to flare severity; the evidence base and guidance treat regular emollient use plus appropriately potent topical steroids as first-line, not a last resort [s1][s2]. This piece is informational and not a prescription: the choice and strength of any topical treatment for a child is a clinical decision.

What the evidence does not support

The site's method is to test popular practices, and bleach baths are a useful case. The idea — that dilute sodium hypochlorite baths cut the bacterial load on eczema-prone skin and calm it — is widely repeated. A systematic review of five studies found that bleach baths did reduce eczema severity, but so did plain water: of four studies comparing bleach with water baths, only two favoured bleach, one favoured water, and one found no difference [s3]. Pooled, there was no significant difference between bleach and water baths at four weeks for either the Eczema Area and Severity Index or affected body-surface area [s3]. The authors' conclusion is that the benefit people see is largely from bathing and moisturising afterwards, not the bleach [s3].

The bigger picture

Eczema in early life is also the usual first step of the so-called atopic march toward asthma and allergic rhinitis, a sequence we examine in the evidence on the atopic march; the overlap with wheeze is one reason a child with eczema is worth watching for childhood asthma. For the small minority of children whose disease is severe and unresponsive to creams, newer injectable biologic drugs have changed what is possible, as covered in our review of eczema biologics — a different tier of treatment from the moisturisers and short steroid courses that manage most childhood eczema.

How to read this

The honest summary is that the boring basics work best: regular moisturising has real, if modest, trial support and reduces both flares and the amount of steroid needed, while topical steroids treat the flares that get through [s1]. Much of the rest — premium moisturiser brands, bleach baths — is not backed by evidence of superiority over cheaper or plainer alternatives [s1][s3]. The most reassuring fact is the natural history: for most children the disease eases as they grow [s2]. This article is informational and is not medical advice; a child whose eczema is severe, infected, or not responding should be assessed by a qualified clinician.